Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?
Identifieur interne : 001758 ( Main/Exploration ); précédent : 001757; suivant : 001759Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?
Auteurs : Felicia Cosman ; Jane A. Cauley ; Richard Eastell ; Steven Boonen ; Lisa Palermo ; Ian R. Reid ; Steven R. Cummings ; Dennis M. BlackSource :
- The Journal of clinical endocrinology and metabolism [ 1945-7197 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Agents de maintien de la densité osseuse (administration et posologie), Agents de maintien de la densité osseuse (usage thérapeutique), Densité osseuse, Diphosphonates (administration et posologie), Diphosphonates (usage thérapeutique), Femelle, Fractures osseuses (), Fractures osseuses (épidémiologie), Humains, Imidazoles (administration et posologie), Imidazoles (usage thérapeutique), Ostéoporose (traitement médicamenteux), Post-ménopause, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Évaluation des risques.
- MESH :
- administration et posologie : Agents de maintien de la densité osseuse, Diphosphonates, Imidazoles.
- traitement médicamenteux : Ostéoporose.
- usage thérapeutique : Agents de maintien de la densité osseuse, Diphosphonates, Imidazoles.
- épidémiologie : Fractures osseuses.
- Adulte, Adulte d'âge moyen, Densité osseuse, Femelle, Fractures osseuses, Humains, Post-ménopause, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Évaluation des risques.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Bone Density, Bone Density Conservation Agents (administration & dosage), Bone Density Conservation Agents (therapeutic use), Diphosphonates (administration & dosage), Diphosphonates (therapeutic use), Female, Fractures, Bone (epidemiology), Fractures, Bone (prevention & control), Humans, Imidazoles (administration & dosage), Imidazoles (therapeutic use), Middle Aged, Osteoporosis (drug therapy), Postmenopause, Risk Assessment, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Bone Density Conservation Agents, Diphosphonates, Imidazoles.
- chemical , therapeutic use : Bone Density Conservation Agents, Diphosphonates, Imidazoles.
- drug therapy : Osteoporosis.
- epidemiology : Fractures, Bone.
- prevention & control : Fractures, Bone.
- Adult, Aged, Aged, 80 and over, Bone Density, Female, Humans, Middle Aged, Postmenopause, Risk Assessment, Treatment Outcome.
Abstract
Data are needed to guide therapeutic decisions about stopping bisphosphonates after an initial treatment period.
DOI: 10.1210/jc.2014-1971
PubMed: 25215556
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000F26
- to stream PubMed, to step Curation: 000F23
- to stream PubMed, to step Checkpoint: 000F23
- to stream Ncbi, to step Merge: 003510
- to stream Ncbi, to step Curation: 003510
- to stream Ncbi, to step Checkpoint: 003510
- to stream Main, to step Merge: 001805
- to stream Main, to step Curation: 001758
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?</title><author><name sortKey="Cosman, Felicia" sort="Cosman, Felicia" uniqKey="Cosman F" first="Felicia" last="Cosman">Felicia Cosman</name><affiliation><nlm:affiliation>Helen Hayes Hospital (F.C.), West Haverstraw, New York 10993; Department of Medicine (F.C.), Columbia University College of Physicians and Surgeons, New York, New York 10032; Department of Epidemiology (J.A.C.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Academic Unit of Bone Metabolism (R.E.), University of Sheffield, Sheffield, United Kingdon, S5 7AU; Department of Experimental Medicine (S.B.); Leuven University Hospital, Leuven, B-3000 Belgium; Department of Epidemiology and Department of Biostatistics (L.P., S.R.C., D.M.B.), University of California San Francisco, San Francisco, California 94107; and Faculty of Medical and Health Sciences (I.R.R.), University of Auckland, Auckland, New Zealand, 1023.</nlm:affiliation><wicri:noCountry code="subField">1023</wicri:noCountry></affiliation></author><author><name sortKey="Cauley, Jane A" sort="Cauley, Jane A" uniqKey="Cauley J" first="Jane A" last="Cauley">Jane A. Cauley</name></author><author><name sortKey="Eastell, Richard" sort="Eastell, Richard" uniqKey="Eastell R" first="Richard" last="Eastell">Richard Eastell</name></author><author><name sortKey="Boonen, Steven" sort="Boonen, Steven" uniqKey="Boonen S" first="Steven" last="Boonen">Steven Boonen</name></author><author><name sortKey="Palermo, Lisa" sort="Palermo, Lisa" uniqKey="Palermo L" first="Lisa" last="Palermo">Lisa Palermo</name></author><author><name sortKey="Reid, Ian R" sort="Reid, Ian R" uniqKey="Reid I" first="Ian R" last="Reid">Ian R. Reid</name></author><author><name sortKey="Cummings, Steven R" sort="Cummings, Steven R" uniqKey="Cummings S" first="Steven R" last="Cummings">Steven R. Cummings</name></author><author><name sortKey="Black, Dennis M" sort="Black, Dennis M" uniqKey="Black D" first="Dennis M" last="Black">Dennis M. Black</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25215556</idno><idno type="pmid">25215556</idno><idno type="doi">10.1210/jc.2014-1971</idno><idno type="wicri:Area/PubMed/Corpus">000F26</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F26</idno><idno type="wicri:Area/PubMed/Curation">000F23</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F23</idno><idno type="wicri:Area/PubMed/Checkpoint">000F23</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F23</idno><idno type="wicri:Area/Ncbi/Merge">003510</idno><idno type="wicri:Area/Ncbi/Curation">003510</idno><idno type="wicri:Area/Ncbi/Checkpoint">003510</idno><idno type="wicri:Area/Main/Merge">001805</idno><idno type="wicri:Area/Main/Curation">001758</idno><idno type="wicri:Area/Main/Exploration">001758</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?</title><author><name sortKey="Cosman, Felicia" sort="Cosman, Felicia" uniqKey="Cosman F" first="Felicia" last="Cosman">Felicia Cosman</name><affiliation><nlm:affiliation>Helen Hayes Hospital (F.C.), West Haverstraw, New York 10993; Department of Medicine (F.C.), Columbia University College of Physicians and Surgeons, New York, New York 10032; Department of Epidemiology (J.A.C.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Academic Unit of Bone Metabolism (R.E.), University of Sheffield, Sheffield, United Kingdon, S5 7AU; Department of Experimental Medicine (S.B.); Leuven University Hospital, Leuven, B-3000 Belgium; Department of Epidemiology and Department of Biostatistics (L.P., S.R.C., D.M.B.), University of California San Francisco, San Francisco, California 94107; and Faculty of Medical and Health Sciences (I.R.R.), University of Auckland, Auckland, New Zealand, 1023.</nlm:affiliation><wicri:noCountry code="subField">1023</wicri:noCountry></affiliation></author><author><name sortKey="Cauley, Jane A" sort="Cauley, Jane A" uniqKey="Cauley J" first="Jane A" last="Cauley">Jane A. Cauley</name></author><author><name sortKey="Eastell, Richard" sort="Eastell, Richard" uniqKey="Eastell R" first="Richard" last="Eastell">Richard Eastell</name></author><author><name sortKey="Boonen, Steven" sort="Boonen, Steven" uniqKey="Boonen S" first="Steven" last="Boonen">Steven Boonen</name></author><author><name sortKey="Palermo, Lisa" sort="Palermo, Lisa" uniqKey="Palermo L" first="Lisa" last="Palermo">Lisa Palermo</name></author><author><name sortKey="Reid, Ian R" sort="Reid, Ian R" uniqKey="Reid I" first="Ian R" last="Reid">Ian R. Reid</name></author><author><name sortKey="Cummings, Steven R" sort="Cummings, Steven R" uniqKey="Cummings S" first="Steven R" last="Cummings">Steven R. Cummings</name></author><author><name sortKey="Black, Dennis M" sort="Black, Dennis M" uniqKey="Black D" first="Dennis M" last="Black">Dennis M. Black</name></author></analytic><series><title level="j">The Journal of clinical endocrinology and metabolism</title><idno type="eISSN">1945-7197</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Bone Density</term><term>Bone Density Conservation Agents (administration & dosage)</term><term>Bone Density Conservation Agents (therapeutic use)</term><term>Diphosphonates (administration & dosage)</term><term>Diphosphonates (therapeutic use)</term><term>Female</term><term>Fractures, Bone (epidemiology)</term><term>Fractures, Bone (prevention & control)</term><term>Humans</term><term>Imidazoles (administration & dosage)</term><term>Imidazoles (therapeutic use)</term><term>Middle Aged</term><term>Osteoporosis (drug therapy)</term><term>Postmenopause</term><term>Risk Assessment</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents de maintien de la densité osseuse (administration et posologie)</term><term>Agents de maintien de la densité osseuse (usage thérapeutique)</term><term>Densité osseuse</term><term>Diphosphonates (administration et posologie)</term><term>Diphosphonates (usage thérapeutique)</term><term>Femelle</term><term>Fractures osseuses ()</term><term>Fractures osseuses (épidémiologie)</term><term>Humains</term><term>Imidazoles (administration et posologie)</term><term>Imidazoles (usage thérapeutique)</term><term>Ostéoporose (traitement médicamenteux)</term><term>Post-ménopause</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Bone Density Conservation Agents</term><term>Diphosphonates</term><term>Imidazoles</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bone Density Conservation Agents</term><term>Diphosphonates</term><term>Imidazoles</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents de maintien de la densité osseuse</term><term>Diphosphonates</term><term>Imidazoles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Osteoporosis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Fractures, Bone</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Fractures, Bone</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Ostéoporose</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents de maintien de la densité osseuse</term><term>Diphosphonates</term><term>Imidazoles</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Fractures osseuses</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Bone Density</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Postmenopause</term><term>Risk Assessment</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Densité osseuse</term><term>Femelle</term><term>Fractures osseuses</term><term>Humains</term><term>Post-ménopause</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Data are needed to guide therapeutic decisions about stopping bisphosphonates after an initial treatment period.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Black, Dennis M" sort="Black, Dennis M" uniqKey="Black D" first="Dennis M" last="Black">Dennis M. Black</name><name sortKey="Boonen, Steven" sort="Boonen, Steven" uniqKey="Boonen S" first="Steven" last="Boonen">Steven Boonen</name><name sortKey="Cauley, Jane A" sort="Cauley, Jane A" uniqKey="Cauley J" first="Jane A" last="Cauley">Jane A. Cauley</name><name sortKey="Cosman, Felicia" sort="Cosman, Felicia" uniqKey="Cosman F" first="Felicia" last="Cosman">Felicia Cosman</name><name sortKey="Cummings, Steven R" sort="Cummings, Steven R" uniqKey="Cummings S" first="Steven R" last="Cummings">Steven R. Cummings</name><name sortKey="Eastell, Richard" sort="Eastell, Richard" uniqKey="Eastell R" first="Richard" last="Eastell">Richard Eastell</name><name sortKey="Palermo, Lisa" sort="Palermo, Lisa" uniqKey="Palermo L" first="Lisa" last="Palermo">Lisa Palermo</name><name sortKey="Reid, Ian R" sort="Reid, Ian R" uniqKey="Reid I" first="Ian R" last="Reid">Ian R. Reid</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001758 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001758 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25215556
|texte= Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25215556" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |